AcuraStem Enters into a License Agreement with Takeda to Advance PIKFYVE Therapeutics

/PRNewswire/ -- AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that...

Related Keywords

Monrovia ,Montserrado ,Liberia ,Prnewswire Acurastem ,Sam Alworth ,Justin Ichida ,Qing Liu ,Sarah Sheikh ,Foley Hoag ,Stevens Center ,Alzheimer Association ,Department Of Defense ,Rainwater Charitable Foundation ,Harrington Discovery Institute ,National Institute Of Neurological Disorders ,Alzheimer Drug Discovery Foundation ,Amyotrophic Lateral Sclerosis ,Frontotemporal Dementia ,Hungs T ,Neuroscience Therapeutic Area Unit ,Paul August ,Drug Discovery Foundation ,National Institute ,Neurological Disorders ,Acurastem Patient Based Therapeutics ,